Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

InfuSystem Holdings, Inc.

INFUAMEX
Healthcare
Medical - Instruments & Supplies
$9.57
$0.26(2.79%)
U.S. Market opens in 15h 28m

InfuSystem Holdings, Inc. Fundamental Analysis

InfuSystem Holdings, Inc. (INFU) shows moderate financial fundamentals with a PE ratio of 29.51, profit margin of 4.62%, and ROE of 11.91%. The company generates $0.1B in annual revenue with moderate year-over-year growth of 6.36%.

Key Strengths

Current Ratio1.80

Areas of Concern

Operating Margin8.31%
Cash Position1.64%
We analyze INFU's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 51.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
51.8/100

We analyze INFU's fundamental strength across five key dimensions:

Efficiency Score

Weak

INFU struggles to generate sufficient returns from assets.

ROA > 10%
6.59%

Valuation Score

Moderate

INFU shows balanced valuation metrics.

PE < 25
29.51
PEG Ratio < 2
1.28

Growth Score

Moderate

INFU shows steady but slowing expansion.

Revenue Growth > 5%
6.36%
EPS Growth > 10%
1.91%

Financial Health Score

Excellent

INFU maintains a strong and stable balance sheet.

Debt/Equity < 1
0.06
Current Ratio > 1
1.80

Profitability Score

Weak

INFU struggles to sustain strong margins.

ROE > 15%
11.91%
Net Margin ≥ 15%
4.62%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is INFU Expensive or Cheap?

P/E Ratio

INFU trades at 29.51 times earnings. This indicates a fair valuation.

29.51

PEG Ratio

When adjusting for growth, INFU's PEG of 1.28 indicates fair valuation.

1.28

Price to Book

The market values InfuSystem Holdings, Inc. at 3.41 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.41

EV/EBITDA

Enterprise value stands at 7.72 times EBITDA. This is generally considered low.

7.72

How Well Does INFU Make Money?

Net Profit Margin

For every $100 in sales, InfuSystem Holdings, Inc. keeps $4.62 as profit after all expenses.

4.62%

Operating Margin

Core operations generate 8.31 in profit for every $100 in revenue, before interest and taxes.

8.31%

ROE

Management delivers $11.91 in profit for every $100 of shareholder equity.

11.91%

ROA

InfuSystem Holdings, Inc. generates $6.59 in profit for every $100 in assets, demonstrating efficient asset deployment.

6.59%

Following the Money - Real Cash Generation

Operating Cash Flow

InfuSystem Holdings, Inc. produces operating cash flow of $24.45M, showing steady but balanced cash generation.

$24.45M

Free Cash Flow

InfuSystem Holdings, Inc. generates strong free cash flow of $22.86M, providing ample flexibility for dividends, buybacks, or growth.

$22.86M

FCF Per Share

Each share generates $1.12 in free cash annually.

$1.12

FCF Yield

INFU converts 11.71% of its market value into free cash.

11.71%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

29.51

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.28

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.41

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.37

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.80

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.12

vs 25 benchmark

ROA

Return on assets percentage

0.07

vs 25 benchmark

ROCE

Return on capital employed

0.15

vs 25 benchmark

How INFU Stacks Against Its Sector Peers

MetricINFU ValueSector AveragePerformance
P/E Ratio29.5128.25 Neutral
ROE11.91%780.00% Weak
Net Margin4.62%-20122.00% (disorted) Weak
Debt/Equity0.060.30 Strong (Low Leverage)
Current Ratio1.804.66 Neutral
ROA6.59%-14687.00% (disorted) Weak

INFU outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews InfuSystem Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

43.36%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-17.90%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

17.15%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ